Summary by Futu AI
On June 26, 2024, Shanghai Fosun Pharma (Group) Co., Ltd. held the 2023 shareholder meeting, the 2024 first A-share category shareholder meeting, and the H-share category shareholder meeting. Guohao Lawyer (Shanghai) Law Firm attended and provided a legal opinion, confirming that the call-up and convening procedures, the qualifications of attendees, convener's qualifications, meeting voting procedures and results all comply with relevant laws and regulations and the company's articles of association. The shareholders' meeting passed the proposals listed in the meeting notice, except for one proposal at the H-share category shareholder meeting, all other voting matters were validly passed. The meeting combined on-site voting with online voting and conducted statistics on each proposal after the meeting. The legal opinion for this shareholder meeting will serve as a statutory document of the company's announcement, submitted to the Shanghai Stock Exchange for review and announcement.